- Home
- TPCS vs ICUCW Comparison
TPCS vs ICUCW Comparison
Compare TPCS & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPCS
- ICUCW
- Stock Information
- Founded
- TPCS 1956
- ICUCW N/A
- Country
- TPCS United States
- ICUCW United States
- Employees
- TPCS N/A
- ICUCW 19
- Industry
- TPCS Metal Fabrications
- ICUCW Biotechnology: Pharmaceutical Preparations
- Sector
- TPCS Industrials
- ICUCW Health Care
- Exchange
- TPCS Nasdaq
- ICUCW Nasdaq
- Market Cap
- TPCS N/A
- ICUCW N/A
- IPO Year
- TPCS N/A
- ICUCW 2021
- Fundamental
- Price
- TPCS $3.17
- ICUCW $0.03
- Analyst Decision
- TPCS
- ICUCW
- Analyst Count
- TPCS 0
- ICUCW 0
- Target Price
- TPCS N/A
- ICUCW N/A
- AVG Volume (30 Days)
- TPCS 40.8K
- ICUCW N/A
- Earning Date
- TPCS 04-08-2025
- ICUCW N/A
- Dividend Yield
- TPCS N/A
- ICUCW N/A
- EPS Growth
- TPCS N/A
- ICUCW N/A
- EPS
- TPCS N/A
- ICUCW N/A
- Revenue
- TPCS $33,154,058.00
- ICUCW N/A
- Revenue This Year
- TPCS N/A
- ICUCW N/A
- Revenue Next Year
- TPCS N/A
- ICUCW N/A
- P/E Ratio
- TPCS N/A
- ICUCW N/A
- Revenue Growth
- TPCS 8.71
- ICUCW N/A
- 52 Week Low
- TPCS $2.05
- ICUCW N/A
- 52 Week High
- TPCS $4.99
- ICUCW N/A
- Technical
- Relative Strength Index (RSI)
- TPCS 72.00
- ICUCW N/A
- Support Level
- TPCS $2.83
- ICUCW N/A
- Resistance Level
- TPCS $3.00
- ICUCW N/A
- Average True Range (ATR)
- TPCS 0.18
- ICUCW 0.00
- MACD
- TPCS 0.08
- ICUCW 0.00
- Stochastic Oscillator
- TPCS 83.81
- ICUCW 0.00
About ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.